PUBLIC COMPANY
saveBrii Biosciences Ltd
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection
- phase2Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
- phase2A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
- phase2A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
- phase2Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)
- phase2Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China
- phase1A Study of BRII-297 in Healthy Adult Subjects
🐶 Hiring Signal
News
- Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilotPlus news about Brii Biosciences. 💰 How AbbVie got Apogee: The Chicago-area drug giant snagged Apogee Therapeutics for $10.9 billion last month after years of talking with the biotech. AbbVie held…endpoints · 1mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that